Recruiting OBSERVATIONAL NCT05991336

Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

Growth and Development, Health-related Quality of Life of Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

Sponsor: Institute of Hematology & Blood Diseases Hospital, China

Conditions Gene Therapy Transfusion-dependent Beta-Thalassemia

Interventions Gene therapy

Updated 4 times since 2023 Last updated: Aug 6, 2023 Started: Jun 5, 2023 Primary completion: Dec 31, 2028 Completion: Dec 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Gene Therapy and Transfusion-dependent Beta-Thalassemia and is currently actively recruiting participants. Institute of Hematology & Blood Diseases Hospital, China leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Oct 2023 — Jul 2024 [monthly]

Recruiting
Sep 2023 — Oct 2023 [monthly]

Recruiting

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institute of Hematology & Blood Diseases Hospital, China

Data source: Institute of Hematology & Blood Diseases Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tianjin, China